Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and Cancer of Nasopharynx

organophosphonates has been researched along with Cancer of Nasopharynx in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D1
Pagano, JS; Raab-Traub, N; Wakisaka, N; Yoshizaki, T1
Furukawa, M; Kondo, S; Murono, S; Nakashima, M; Shimizu, Y; Tsuji, A; Wakisaka, N; Yoshizaki, T1
De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R1
Murono, S; Pagano, JS; Raab-Traub, N1

Other Studies

5 other study(ies) available for organophosphonates and Cancer of Nasopharynx

ArticleYear
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Oncogene, 2003, Apr-17, Volume: 22, Issue:15

    Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays

2003
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
    International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme Inhibitors; Epstein-Barr Virus Infections; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Ribonucleotide Reductases; Transplantation, Heterologous; Tumor Cells, Cultured

2005
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
    Journal of medical virology, 2008, Volume: 80, Issue:5

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Epstein-Barr Virus Infections; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Organophosphonates; Pharynx; Radiography; Ribosomal Proteins; RNA-Binding Proteins

2008
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
    Cancer research, 1998, Feb-01, Volume: 58, Issue:3

    Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Female; Ganciclovir; Genes, p53; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Injections, Intralesional; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Tumor Virus Infections

1998
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Cancer research, 2001, Nov-01, Volume: 61, Issue:21

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cidofovir; Cytosine; Epithelial Cells; Growth Inhibitors; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Tenofovir; Xenograft Model Antitumor Assays

2001